Annual Cash & Cash Equivalents
$1.67B$53.05M+3.29%
Summary
- Current Value
- As of today, BIO annual cash & cash equivalents is $1.67B, up +3.29% on
- Historical Performance
- BIO annual cash & cash equivalents is up +90.28% over the past 3 years, and up +48.70% over the past 5 years
- All-Time High Comparison
- BIO annual cash & cash equivalents is currently -7.26% below its historical high of $1.80B set on
- 3-Year Low Comparison
- BIO annual cash & cash equivalents is +3.29% above its 3-year low of $1.61B reached on
- Sector Comparison
- BIO annual cash & cash equivalents is higher than 95.09% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $1.67B | +3.3% | +90.3% | +48.7% | +123.7% | |
| Quarterly Cash & Cash Equivalents | $1.42B | -12.8% | -23.4% | +22.1% | +92.5% | |
| Price | $325.50 | -5.2% | -22.3% | -46.8% | +208.5% | |
| Annual Current Assets | $3.03B | -0.6% | +52.2% | +39.0% | +93.9% | |
| Annual Total Liabilities | $2.79B | -21.4% | -32.1% | +24.0% | +122.4% | |
| Annual Working Capital | $2.56B | +1.5% | +95.7% | +101.0% | +124.3% | |
| Annual Net Income | -$1.84B | -189.4% | -143.3% | -204.9% | -1336.3% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.80B | N/A | -7.3% |
| 5Y | $1.80B | -7.3% | |
| All | $1.80B | -7.3% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.61B | +3.3% | |
| 5Y | $875.49M | +90.3% | |
| All | $832.00K | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of BIO?
As of today, BIO annual cash & cash equivalents is $1.67B
What is 1-year change in BIO annual cash & cash equivalents?
BIO annual cash & cash equivalents is up +3.29% year-over-year
What is 3-year change in BIO annual cash & cash equivalents?
BIO annual cash & cash equivalents is up +90.28% over the past 3 years
How far is BIO annual cash & cash equivalents from its all-time high?
BIO annual cash & cash equivalents is currently -7.26% below its historical high of $1.80B set on December 31, 2022
How does BIO annual cash & cash equivalents rank versus sector peers?
BIO annual cash & cash equivalents is higher than 95.09% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly Cash & Cash Equivalents
$1.42B$44.80M+3.26%
Summary
- Current Value
- As of today, BIO quarterly cash & cash equivalents is $1.42B, up +3.26% on
- Historical Performance
- BIO quarterly cash & cash equivalents is down -12.81% year-over-year, and down -23.45% over the past 3 years
- All-Time High Comparison
- BIO quarterly cash & cash equivalents is currently -31.67% below its historical high of $2.08B set on
- 3-Year Low Comparison
- BIO quarterly cash & cash equivalents is +3.26% above its 3-year low of $1.38B reached on
- Sector Comparison
- BIO quarterly cash & cash equivalents is higher than 94.29% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $1.42B | +3.3% | -12.8% | -23.4% | +22.1% | |
| Annual Cash & Cash Equivalents | $1.67B | – | +3.3% | +90.3% | +48.7% | |
| Price | $325.50 | +5.3% | -5.2% | -22.3% | -46.8% | |
| Quarterly Current Assets | $2.84B | +1.1% | -7.0% | -9.5% | +22.3% | |
| Quarterly Total Liabilities | $2.96B | -4.1% | -5.0% | -17.9% | -7.4% | |
| Quarterly Working Capital | $2.32B | +2.5% | -9.3% | -9.7% | +73.5% | |
| Quarterly Net Income | -$341.90M | -207.6% | -152.3% | -110.0% | -126.0% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.67B | N/A | -14.7% |
| 3Y | $1.86B | -23.5% | |
| 5Y | $2.08B | -31.7% | |
| All | $2.08B | -31.7% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.38B | +3.3% | |
| 3Y | $1.38B | +3.3% | |
| 5Y | $875.49M | +62.3% | |
| All | $900.00K | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of BIO?
As of today, BIO quarterly cash & cash equivalents is $1.42B
What is BIO quarterly cash & cash equivalents most recent change?
BIO quarterly cash & cash equivalents was up +3.26% on September 30, 2025
What is 1-year change in BIO quarterly cash & cash equivalents?
BIO quarterly cash & cash equivalents is down -12.81% year-over-year
How far is BIO quarterly cash & cash equivalents from its all-time high?
BIO quarterly cash & cash equivalents is currently -31.67% below its historical high of $2.08B set on March 31, 2022
How does BIO quarterly cash & cash equivalents rank versus sector peers?
BIO quarterly cash & cash equivalents is higher than 94.29% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio